Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
66.30    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.80 (5.901%)
Market Cap: £113.97m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Net Asset Value and Dividend Declaration

24 Jul 2025 07:00

RNS Number : 2862S
GCP Asset Backed Income Fund Ltd
24 July 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

24 July 2025

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815

Net Asset Value and Dividend Declaration

The Company announces that as of 30 June 2025, the unaudited net asset value ("NAV") per ordinary share (including current period revenue) was 79.79 pence per share.

NAV Movement

The NAV per ordinary share decreased by 2.01 pence (2.46%) since the 31 December 2024 audited annual report and accounts. This movement reflects (i) revised estimates of future recoverable amounts, based on updated valuation assumptions and progress in realisation discussions or agreements; and (ii) asset-specific performance impacts, as advised by the Company's independent valuation agent.

Given the commercial sensitivity of ongoing realisation discussions and the increasingly concentrated nature of the portfolio, the Company does not intend to provide further asset-level detail on NAV movements. Further information will be included in the interim accounts for the six-month period ended 30 June 2025, and future disclosures will only be made where such detail would not prejudice the Company's objective of maximising shareholder returns through the orderly realisation of its assets.

Realisations & Capital Allocation

The Company has continued to execute its capital return strategy following the Discontinuation Vote in May 2024, including two compulsory share redemptions and the cancellation of treasury shares, resulting in a 51.22% reduction in share capital to date. Approximately £188.2 million has been returned to shareholders, with 215,606,413 shares remaining in issue as at 30 June 2025.

As at 24 July 2025, the Company and its subsidiaries held a cash balance of approximately £20 million (30 June 2025: £18.4 million), supported by scheduled repayments and further realisations. During the six-month period ended 30 June 2025, the Company received approximately £12 million in loan repayments and other cash realisations. The Board is currently assessing the appropriate level of cash reserves to support the Company's ongoing obligations, including the potential for further capital distributions, the maintenance of the quarterly dividend, and limited potential follow-on investments where necessary to maximise the recovery of existing exposures. Further redemptions remain under consideration, subject to the timing and quantum of future realisations and the Company's liquidity requirements.

The Company's Board of Directors (the "Board") and Gravis Capital Management Ltd, the Investment Manager, continue to progress a pipeline of disposals and remain committed to the orderly realisation of the Company's assets in line with the Realisation Plan published in July 2024 and the update provided as part of the Company's annual report and accounts relating to the period ending 31 December 2024 published on 30 April 2025 and available on the Company's website.

Post-period end, the Company completed the sale of one of its problem loan assets for cash consideration in line with its December 2024 fair value. This asset formed part of the "rump" assets identified in the July 2024 Realisation Plan.

The Company's revised objective remains the orderly realisation of its assets to maximise shareholder returns. Accordingly, the Company will only make new investments where the Board believes doing so will protect, enhance, or accelerate the recovery of an existing investment. As noted in the RNS dated 12 February 2025 a small investment of £0.06 million was made during the period to support an existing development project.

Dividends

The Board is pleased to announce a quarterly dividend in respect of the period from 1 April 2025 to 30 June 2025 of 1.58125 pence per ordinary share (the "Q2 Dividend").

The Company's ordinary shares will go ex-dividend on 31 July 2025 and the Q2 Dividend will be paid on 1 September 2025 to holders of ordinary shares recorded on the register as at close of business on 1 August 2025.

For further information:

GCP Asset Backed Income Fund Limited

Alex Ohlsson, Chairman

+44 (0)15 3482 2251

Gravis Capital Management Limited - Investment Manager

Philip Kent

Luther Ward-Faint

Cameron Gardner

+44 (0)20 3405 8500

Barclays Bank PLC, acting through its Investment Bank - Corporate Broker

Dion Di Miceli

Stuart Muress

James Atkinson

 

+44 (0) 20 7623 2323

BarclaysInvestmentCompanies@barclays.com

Buchanan/Quill - Media Enquiries

Helen Tarbet

Henry Wilson

Nick Croysdill 

+44 (0)20 7466 5000

Notes to the Editor

About GABI

GCP Asset Backed Income Fund Limited is a closed ended investment company. Its shares are traded on the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.

The Company's portfolio comprises a diversified portfolio of predominantly UK based asset backed loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVRJMITMTTTBMA
Date   Source Headline
22nd Aug 20187:00 amRNSAdditional Listing
21st Aug 201810:04 amRNSRevolving Credit Facility
9th Aug 20187:00 amRNSScrip Share Reference Price
1st Aug 20187:00 amRNSInvestor Report as at 30 June 2018
26th Jul 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
26th Jul 20187:00 amRNSSpecial dividend declaration
26th Jul 20187:00 amRNSProposed C Share issue
16th Jul 20187:00 amRNSNet Asset Value(s)
29th Jun 20187:00 amRNSTotal Voting Rights
14th Jun 20185:21 pmRNSHolding(s) in Company
7th Jun 20187:00 amRNSResult of AGM
5th Jun 20189:15 amRNSAdditional Listing
24th May 20187:00 amRNSAdditional Listing
11th May 20187:00 amRNSScrip Reference Price
4th May 201811:15 amRNSNotice of AGM
30th Apr 20187:00 amRNSTotal Voting Rights
27th Apr 20187:00 amRNSInvestor Report as at March 2018
26th Apr 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
26th Apr 20187:00 amRNSAnnual Report & Financial Statements
26th Apr 20187:00 amRNSAnnual Scrip Dividend Circular 2018
17th Apr 20181:31 pmRNSTotal Voting Rights & Additional Listing
16th Apr 20187:25 amRNSConversion of C shares
11th Apr 20187:00 amRNSNet Asset Value(s)
12th Mar 20187:00 amRNSConversion of C Shares
28th Feb 20187:00 amRNSTotal Voting Rights
23rd Feb 20188:15 amRNSTotal Voting Rights & Additional Listing
16th Feb 20187:00 amRNSAdditional Listing
1st Feb 20187:00 amRNSScrip Share Reference Price
30th Jan 201810:32 amRNSInvestor Report as at 31 December 2017
17th Jan 20183:26 pmRNSDividend Declaration & Scrip Dividend Alternative
17th Jan 20187:00 amRNSNet Asset Value(s)
20th Dec 201710:11 amRNSReplacement: Holding(s) in Company
19th Dec 20177:00 amRNSMarkets in Financial Instruments Directive
30th Nov 201712:50 pmRNSTotal Voting Rights
30th Nov 20177:00 amRNSC Share Portfolio Update
16th Nov 201712:20 pmRNSAdditional Listing
2nd Nov 20177:00 amRNSScrip Share Reference Price
1st Nov 20177:00 amRNSInvestor Report as at 30 September 2017
19th Oct 20177:00 amRNSDividend Declaration & Scrip Dividend Alternative
18th Oct 20177:00 amRNSNet Asset Value(s)
16th Oct 201712:51 pmRNSHolding(s) in Company
12th Oct 20177:00 amRNSResult of OO, Placing and OFS
29th Sep 20172:51 pmRNSTotal Voting Rights
25th Sep 201711:40 amRNSC Share Issue and publication of prospectus
22nd Sep 20177:00 amRNSInterim Report and Financial Statements
4th Sep 20171:37 pmRNSAdditional Listing
4th Sep 20177:00 amRNSNew Website
31st Aug 201712:16 pmRNSTotal Voting Rights
22nd Aug 201710:50 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20179:54 amRNSProposed C Share Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.